(CVX) Chevron - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1667641005
Stock: Oil, Gas, Refining, Chemicals, Fuels
Total Rating 53
Risk 74
Buy Signal 0.20
| Risk 5d forecast | |
|---|---|
| Volatility | 21.1% |
| Relative Tail Risk | 0.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.01 |
| Alpha | 18.14 |
| Character TTM | |
|---|---|
| Beta | 0.746 |
| Beta Downside | 1.803 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.64% |
| CAGR/Max DD | 0.52 |
EPS (Earnings per Share)
Revenue
Description: CVX Chevron March 04, 2026
Chevron Corporation (CVX) is an integrated energy company with operations in the United States and globally. Its business model spans the full energy value chain.
The Upstream segment focuses on exploration, development, production, and transportation of crude oil and natural gas. This includes liquefied natural gas (LNG) activities and carbon capture technologies, reflecting a broader industry trend towards emission reduction.
The Downstream segment refines crude oil into petroleum products, markets these products and lubricants, and manufactures renewable fuels. This segment also involves extensive logistics for crude and refined product transport, a core component of the oil and gas sector.
For more detailed financial analysis, ValueRay offers comprehensive company profiles.
Headlines to watch out for
- Global crude oil prices dictate upstream profitability
- Natural gas demand impacts LNG and pipeline revenue
- Refining margins influenced by product crack spreads
- Regulatory changes on carbon emissions increase operating costs
- Geopolitical stability affects international production
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 12.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.96 > 1.0 |
| NWC/Revenue: 2.78% < 20% (prev 1.22%; Δ 1.56% < -1%) |
| CFO/TA 0.10 > 3% & CFO 33.75b > Net Income 12.31b |
| Net Debt (40.28b) to EBITDA (41.09b): 0.98 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.00b) vs 12m ago 12.36% < -2% |
| Gross Margin: 14.74% > 18% (prev 0.29%; Δ 1445 % > 0.5%) |
| Asset Turnover: 64.01% > 50% (prev 75.28%; Δ -11.26% > 0%) |
| Interest Coverage Ratio: 17.22 > 6 (EBITDA TTM 41.09b / Interest Expense TTM 1.22b) |
Altman Z'' 4.28
| A: 0.02 (Total Current Assets 38.55b - Total Current Liabilities 33.39b) / Total Assets 324.01b |
| B: 0.63 (Retained Earnings 205.37b / Total Assets 324.01b) |
| C: 0.07 (EBIT TTM 20.96b / Avg Total Assets 290.48b) |
| D: 1.55 (Book Value of Equity 204.49b / Total Liabilities 131.84b) |
| Altman-Z'' Score: 4.28 = AA |
Beneish M -2.48
| DSRI: 0.91 (Receivables 18.07b/20.68b, Revenue 185.94b/193.41b) |
| GMI: 2.00 (GM 14.74% / 29.43%) |
| AQI: 0.69 (AQ_t 0.18 / AQ_t-1 0.27) |
| SGI: 0.96 (Revenue 185.94b / 193.41b) |
| TATA: -0.07 (NI 12.31b - CFO 33.75b) / TA 324.01b) |
| Beneish M-Score: -2.48 (Cap -4..+1) = BBB |
What is the price of CVX shares?
As of March 09, 2026, the stock is trading at USD 189.94 with a total of 13,063,934 shares traded.
Over the past week, the price has changed by +0.18%, over one month by +5.04%, over three months by +28.97% and over the past year by +25.97%.
Over the past week, the price has changed by +0.18%, over one month by +5.04%, over three months by +28.97% and over the past year by +25.97%.
Is CVX a buy, sell or hold?
Chevron has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy CVX.
- StrongBuy: 9
- Buy: 6
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 185.9 | -2.1% |
| Analysts Target Price | 185.9 | -2.1% |
CVX Fundamental Data Overview March 07, 2026
P/E Trailing = 28.6486
P/E Forward = 24.1546
P/S = 2.0566
P/B = 1.9768
P/EG = 3.6627
Revenue TTM = 185.94b USD
EBIT TTM = 20.96b USD
EBITDA TTM = 41.09b USD
Long Term Debt = 39.12b USD (from longTermDebt, last quarter)
Short Term Debt = 2.81b USD (from shortTermDebt, last quarter)
Debt = 46.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 40.28b USD (from netDebt column, last quarter)
Enterprise Value = 420.03b USD (379.76b + Debt 46.74b - CCE 6.47b)
Interest Coverage Ratio = 17.22 (Ebit TTM 20.96b / Interest Expense TTM 1.22b)
EV/FCF = 25.96x (Enterprise Value 420.03b / FCF TTM 16.18b)
FCF Yield = 3.85% (FCF TTM 16.18b / Enterprise Value 420.03b)
FCF Margin = 8.70% (FCF TTM 16.18b / Revenue TTM 185.94b)
Net Margin = 6.62% (Net Income TTM 12.31b / Revenue TTM 185.94b)
Gross Margin = 14.74% ((Revenue TTM 185.94b - Cost of Revenue TTM 158.53b) / Revenue TTM)
Gross Margin QoQ = 11.36% (prev 11.57%)
Tobins Q-Ratio = 1.30 (Enterprise Value 420.03b / Total Assets 324.01b)
Interest Expense / Debt = 0.77% (Interest Expense 361.0m / Debt 46.74b)
Taxrate = 38.14% (1.75b / 4.60b)
NOPAT = 12.97b (EBIT 20.96b * (1 - 38.14%))
Current Ratio = 1.15 (Total Current Assets 38.55b / Total Current Liabilities 33.39b)
Debt / Equity = 0.25 (Debt 46.74b / totalStockholderEquity, last quarter 186.45b)
Debt / EBITDA = 0.98 (Net Debt 40.28b / EBITDA 41.09b)
Debt / FCF = 2.49 (Net Debt 40.28b / FCF TTM 16.18b)
Total Stockholder Equity = 167.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 12.31b / Total Assets 324.01b)
RoE = 7.33% (Net Income TTM 12.31b / Total Stockholder Equity 167.99b)
RoCE = 10.12% (EBIT 20.96b / Capital Employed (Equity 167.99b + L.T.Debt 39.12b))
RoIC = 6.39% (NOPAT 12.97b / Invested Capital 202.99b)
WACC = 7.76% (E(379.76b)/V(426.50b) * Re(8.66%) + D(46.74b)/V(426.50b) * Rd(0.77%) * (1-Tc(0.38)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.39%
[DCF] Terminal Value 75.83% ; FCFF base≈15.83b ; Y1≈13.01b ; Y5≈9.30b
[DCF] Fair Price = 69.77 (EV 178.50b - Net Debt 40.28b = Equity 138.23b / Shares 1.98b; r=7.76% [WACC]; 5y FCF grow -21.46% → 2.90% )
EPS Correlation: -92.07 | EPS CAGR: -19.07% | SUE: 0.39 | # QB: 0
Revenue Correlation: -72.75 | Revenue CAGR: -3.49% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.65 | Chg7d=-0.012 | Chg30d=+0.000 | Revisions Net=-5 | Analysts=17
EPS current Year (2026-12-31): EPS=6.82 | Chg7d=+0.030 | Chg30d=+0.105 | Revisions Net=-5 | Growth EPS=-6.4% | Growth Revenue=-2.4%
EPS next Year (2027-12-31): EPS=9.17 | Chg7d=+0.011 | Chg30d=+0.223 | Revisions Net=-1 | Growth EPS=+34.4% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -0.38 (4 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 8.7% - Earnings Yield 3.5%)
[Growth] Growth Spread = +0.3% (Analyst 5.4% - Implied 5.2%)
P/E Forward = 24.1546
P/S = 2.0566
P/B = 1.9768
P/EG = 3.6627
Revenue TTM = 185.94b USD
EBIT TTM = 20.96b USD
EBITDA TTM = 41.09b USD
Long Term Debt = 39.12b USD (from longTermDebt, last quarter)
Short Term Debt = 2.81b USD (from shortTermDebt, last quarter)
Debt = 46.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 40.28b USD (from netDebt column, last quarter)
Enterprise Value = 420.03b USD (379.76b + Debt 46.74b - CCE 6.47b)
Interest Coverage Ratio = 17.22 (Ebit TTM 20.96b / Interest Expense TTM 1.22b)
EV/FCF = 25.96x (Enterprise Value 420.03b / FCF TTM 16.18b)
FCF Yield = 3.85% (FCF TTM 16.18b / Enterprise Value 420.03b)
FCF Margin = 8.70% (FCF TTM 16.18b / Revenue TTM 185.94b)
Net Margin = 6.62% (Net Income TTM 12.31b / Revenue TTM 185.94b)
Gross Margin = 14.74% ((Revenue TTM 185.94b - Cost of Revenue TTM 158.53b) / Revenue TTM)
Gross Margin QoQ = 11.36% (prev 11.57%)
Tobins Q-Ratio = 1.30 (Enterprise Value 420.03b / Total Assets 324.01b)
Interest Expense / Debt = 0.77% (Interest Expense 361.0m / Debt 46.74b)
Taxrate = 38.14% (1.75b / 4.60b)
NOPAT = 12.97b (EBIT 20.96b * (1 - 38.14%))
Current Ratio = 1.15 (Total Current Assets 38.55b / Total Current Liabilities 33.39b)
Debt / Equity = 0.25 (Debt 46.74b / totalStockholderEquity, last quarter 186.45b)
Debt / EBITDA = 0.98 (Net Debt 40.28b / EBITDA 41.09b)
Debt / FCF = 2.49 (Net Debt 40.28b / FCF TTM 16.18b)
Total Stockholder Equity = 167.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 12.31b / Total Assets 324.01b)
RoE = 7.33% (Net Income TTM 12.31b / Total Stockholder Equity 167.99b)
RoCE = 10.12% (EBIT 20.96b / Capital Employed (Equity 167.99b + L.T.Debt 39.12b))
RoIC = 6.39% (NOPAT 12.97b / Invested Capital 202.99b)
WACC = 7.76% (E(379.76b)/V(426.50b) * Re(8.66%) + D(46.74b)/V(426.50b) * Rd(0.77%) * (1-Tc(0.38)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.39%
[DCF] Terminal Value 75.83% ; FCFF base≈15.83b ; Y1≈13.01b ; Y5≈9.30b
[DCF] Fair Price = 69.77 (EV 178.50b - Net Debt 40.28b = Equity 138.23b / Shares 1.98b; r=7.76% [WACC]; 5y FCF grow -21.46% → 2.90% )
EPS Correlation: -92.07 | EPS CAGR: -19.07% | SUE: 0.39 | # QB: 0
Revenue Correlation: -72.75 | Revenue CAGR: -3.49% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.65 | Chg7d=-0.012 | Chg30d=+0.000 | Revisions Net=-5 | Analysts=17
EPS current Year (2026-12-31): EPS=6.82 | Chg7d=+0.030 | Chg30d=+0.105 | Revisions Net=-5 | Growth EPS=-6.4% | Growth Revenue=-2.4%
EPS next Year (2027-12-31): EPS=9.17 | Chg7d=+0.011 | Chg30d=+0.223 | Revisions Net=-1 | Growth EPS=+34.4% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -0.38 (4 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 8.7% - Earnings Yield 3.5%)
[Growth] Growth Spread = +0.3% (Analyst 5.4% - Implied 5.2%)